LANXESS adjusts expectations for FY 2023 –  Board of Management proposes dividend reduction

Cologne

Demand in the fourth quarter for specialty chemical products of LANXESS is expected to be lower than estimated. Initiated destocking of customers in the agroindustry and a supplier-related production limitation for the Business Unit Flavors & Fragrances at its production site in Botlek (NL) impact results additionally. 

LANXESS now expects FY 2023 EBITDA pre exceptionals to amount to between EUR 500 and 550 million.  

The adjusted outlook is below the level of market expectations of currently EUR 571 million (Vara Consensus). LANXESS had formerly expected FY 2023 EBITDA pre exceptionals to amount to between EUR 600 and 650 million.  

Given the weak business development, the Board of Management intends to propose a reduction of the FY 2023 dividend to EUR 0.10. The hereby avoided cash outflow would result in a further reduction of net financial debt. Expected proceeds from the now initiated sale of the Business Unit Urethane Systems would contribute as well. 

As the last remaining polymer business at LANXESS, the business unit no longer fits in with the strategic orientation of the Group, which has systematically realigned its portfolio in recent years. The business unit has a global presence with six production sites and employs around 400 staff. 

EBITDA pre exceptionals for the third quarter 2023 is expected to amount to EUR 119 million being in line with the market expectations of currently EUR 120 million. 

LANXESS will release its results for the third quarter 2023 on November 8, 2023. 

Information for editors:
All LANXESS news releases and their accompanying photos can be found at http://press.lanxess.com. Recent photos of the Board of Management and other LANXESS image material are available at http://photos.lanxess.com.

You can find further information concerning LANXESS chemistry at http://lanxess.com/en/Media/Stories.

LANXESS adjusts expectations for FY 2023 –  Board of Management proposes dividend reduction

MORE ABOUT THIS TOPIC

PRESS RELEASE
Since August 1, 2013, specialty chemicals Group LANXESS is steering its global business from the LANXESS Tower in Cologne.

LANXESS increases sales and earnings in the third quarter of 2026

November 09, 2026
PRESS RELEASE
Woman put the cream on skin.

LANXESS Introduces Cosmelin Biodegradable Ester Portfolio for Cosmetics and Personal Care

October 26, 2026
PRESS RELEASE
Packshot Rely+On® Medero

LANXESS will present its new disinfectant, Rely+On Medero, for the first time at Medica 2026

October 22, 2026
PRESS RELEASE
Packshot Rely+On® Medero

LANXESS launches highly effective disinfectant for the medical sector

October 20, 2026
PRESS RELEASE
PIR insulation panel, aluminium-laminated

LANXESS sharpens flame-retardant portfolio for rigid PU and PIR insulation

September 22, 2026